<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Syllabus110817111925-21403a05</title><meta name="author" content="Se7ven"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 13pt; }
 h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; margin:0pt; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; vertical-align: -1pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; vertical-align: 4pt; }
 .s4 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 12pt; }
 .s5 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; vertical-align: -1pt; }
 h3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11.5pt; }
 .s6 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s7 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 1; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 li {display: block; }
 #l2 {padding-left: 0pt;counter-reset: d1 1; }
 #l2> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l3 {padding-left: 0pt;counter-reset: d2 1; }
 #l3> li>*:first-child:before {counter-increment: d2; content: counter(d2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 #l4 {padding-left: 0pt;counter-reset: e1 1; }
 #l4> li>*:first-child:before {counter-increment: e1; content: counter(e1, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 #l5 {padding-left: 0pt;counter-reset: f1 1; }
 #l5> li>*:first-child:before {counter-increment: f1; content: counter(f1, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 #l6 {padding-left: 0pt;counter-reset: f2 1; }
 #l6> li>*:first-child:before {counter-increment: f2; content: counter(f2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 #l7 {padding-left: 0pt;counter-reset: g1 1; }
 #l7> li>*:first-child:before {counter-increment: g1; content: counter(g1, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 #l8 {padding-left: 0pt;counter-reset: g2 1; }
 #l8> li>*:first-child:before {counter-increment: g2; content: counter(g2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: g2 0;  }
 #l9 {padding-left: 0pt;counter-reset: d3 1; }
 #l9> li>*:first-child:before {counter-increment: d3; content: counter(d3, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: d3 0;  }
 #l10 {padding-left: 0pt;counter-reset: d4 1; }
 #l10> li>*:first-child:before {counter-increment: d4; content: counter(d4, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l10> li:first-child>*:first-child:before {counter-increment: d4 0;  }
 li {display: block; }
 #l11 {padding-left: 0pt;counter-reset: h1 1; }
 #l11> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l11> li:first-child>*:first-child:before {counter-increment: h1 0;  }
 #l12 {padding-left: 0pt;counter-reset: h2 1; }
 #l12> li>*:first-child:before {counter-increment: h2; content: counter(h2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l12> li:first-child>*:first-child:before {counter-increment: h2 0;  }
 li {display: block; }
 #l13 {padding-left: 0pt;counter-reset: i1 1; }
 #l13> li>*:first-child:before {counter-increment: i1; content: counter(i1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l13> li:first-child>*:first-child:before {counter-increment: i1 0;  }
 #l14 {padding-left: 0pt;counter-reset: i2 1; }
 #l14> li>*:first-child:before {counter-increment: i2; content: counter(i2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l14> li:first-child>*:first-child:before {counter-increment: i2 0;  }
 #l15 {padding-left: 0pt;counter-reset: i2 1; }
 #l15> li>*:first-child:before {counter-increment: i2; content: counter(i2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l15> li:first-child>*:first-child:before {counter-increment: i2 0;  }
 #l16 {padding-left: 0pt;counter-reset: i2 1; }
 #l16> li>*:first-child:before {counter-increment: i2; content: counter(i2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l16> li:first-child>*:first-child:before {counter-increment: i2 0;  }
 li {display: block; }
 #l17 {padding-left: 0pt;counter-reset: j1 5; }
 #l17> li>*:first-child:before {counter-increment: j1; content: counter(j1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l17> li:first-child>*:first-child:before {counter-increment: j1 0;  }
 #l18 {padding-left: 0pt;counter-reset: j2 1; }
 #l18> li>*:first-child:before {counter-increment: j2; content: counter(j2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l18> li:first-child>*:first-child:before {counter-increment: j2 0;  }
 li {display: block; }
 #l19 {padding-left: 0pt;counter-reset: k1 5; }
 #l19> li>*:first-child:before {counter-increment: k1; content: counter(k1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l19> li:first-child>*:first-child:before {counter-increment: k1 0;  }
 #l20 {padding-left: 0pt;counter-reset: k2 1; }
 #l20> li>*:first-child:before {counter-increment: k2; content: counter(k2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l20> li:first-child>*:first-child:before {counter-increment: k2 0;  }
 #l21 {padding-left: 0pt;counter-reset: k2 1; }
 #l21> li>*:first-child:before {counter-increment: k2; content: counter(k2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l21> li:first-child>*:first-child:before {counter-increment: k2 0;  }
 #l22 {padding-left: 0pt;counter-reset: k3 1; }
 #l22> li>*:first-child:before {counter-increment: k3; content: counter(k3, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l22> li:first-child>*:first-child:before {counter-increment: k3 0;  }
 li {display: block; }
 #l23 {padding-left: 0pt;counter-reset: l1 1; }
 #l23> li>*:first-child:before {counter-increment: l1; content: counter(l1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l23> li:first-child>*:first-child:before {counter-increment: l1 0;  }
 #l24 {padding-left: 0pt;counter-reset: l2 1; }
 #l24> li>*:first-child:before {counter-increment: l2; content: counter(l2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l24> li:first-child>*:first-child:before {counter-increment: l2 0;  }
 li {display: block; }
 #l25 {padding-left: 0pt;counter-reset: m1 1; }
 #l25> li>*:first-child:before {counter-increment: m1; content: counter(m1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l25> li:first-child>*:first-child:before {counter-increment: m1 0;  }
 #l26 {padding-left: 0pt;counter-reset: m2 1; }
 #l26> li>*:first-child:before {counter-increment: m2; content: counter(m2, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l26> li:first-child>*:first-child:before {counter-increment: m2 0;  }
 #l27 {padding-left: 0pt;counter-reset: m3 1; }
 #l27> li>*:first-child:before {counter-increment: m3; content: counter(m3, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l27> li:first-child>*:first-child:before {counter-increment: m3 0;  }
 #l28 {padding-left: 0pt;counter-reset: m4 1; }
 #l28> li>*:first-child:before {counter-increment: m4; content: counter(m4, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l28> li:first-child>*:first-child:before {counter-increment: m4 0;  }
 li {display: block; }
 #l29 {padding-left: 0pt;counter-reset: n1 1; }
 #l29> li>*:first-child:before {counter-increment: n1; content: counter(n1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l29> li:first-child>*:first-child:before {counter-increment: n1 0;  }
 li {display: block; }
 #l30 {padding-left: 0pt;counter-reset: o1 1; }
 #l30> li>*:first-child:before {counter-increment: o1; content: counter(o1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l30> li:first-child>*:first-child:before {counter-increment: o1 0;  }
 li {display: block; }
 #l31 {padding-left: 0pt; }
 #l31> li>*:first-child:before {content: " "; color: black; font-family:Symbol, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l32 {padding-left: 0pt;counter-reset: q1 1; }
 #l32> li>*:first-child:before {counter-increment: q1; content: counter(q1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l32> li:first-child>*:first-child:before {counter-increment: q1 0;  }
</style><link rel="sitemap" type="application/xml" title="Sitemap" href="/sitemap.xml"></head><body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download</button></a></div><script>const a=(window.location.pathname).split(/);const filename=a[a.length-1].replace(".html",".pdf").replace(".htm",".pdf");document.getElementById("pdf-download-link").href=filename;</script><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 11pt;padding-left: 21pt;text-indent: 0pt;text-align: center;">SEMESTER V</h1><h2 style="padding-top: 3pt;padding-left: 17pt;text-indent: 0pt;text-align: center;">PY 501. MEDICINAL CHEMISTRY – II (Theory)</h2><h2 style="padding-top: 6pt;text-indent: 0pt;text-align: right;">45 Hours</h2><h2 style="padding-top: 4pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Scope: <span class="p">This subject is designed to impart fundamental knowledge on the structure, chemistry and therapeutic value of drugs. The subject emphasizes on structure activity relationships of drugs, importance of physicochemical properties and metabolism of drugs. The syllabus also emphasizes on chemical synthesis of important drugs under each class.</span></h2><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Objectives: <span class="p">Upon completion of the course the student shall be able to</span></h2><ol id="l1"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 47pt;text-indent: -17pt;text-align: left;">Understand the chemistry of drugs with respect to their pharmacological activity</p></li><li data-list-text="2."><p style="padding-top: 6pt;padding-left: 47pt;text-indent: -18pt;text-align: left;">Understand the drug metabolic pathways, adverse effect and therapeutic value of drugs</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 47pt;text-indent: -17pt;text-align: left;">Know the Structural Activity Relationship of different class of drugs</p></li><li data-list-text="4."><p style="padding-top: 6pt;padding-left: 47pt;text-indent: -17pt;text-align: left;">Study the chemical synthesis of selected drugs</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 178pt;text-indent: 0pt;text-align: center;">Course Content<span class="p">:</span></h2><p style="padding-left: 16pt;text-indent: 0pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 21pt;text-indent: 0pt;text-align: justify;">Study  of  the development of  the following  classes  of  drugs, Classification, mechanism of action, uses of drugs mentioned in the course, Structure activity relationship of selective class of drugs as specified in the course and synthesis of drugs superscripted (*)</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 21pt;text-indent: 0pt;text-align: justify;">UNIT- I                                     10 Hours</h2><h2 style="padding-top: 11pt;padding-left: 33pt;text-indent: 0pt;text-align: justify;">Antihistaminic agents:  <span class="p">Histamine, receptors and their distribution in the humanbody</span></h2><h2 style="padding-top: 6pt;padding-left: 33pt;text-indent: 0pt;text-align: justify;">H<span class="s1">1</span>–antagonists:        <span class="p">Diphenhydramine hydrochloride*, Dimenhydrinate, Doxylamines cuccinate, Clemastine fumarate, Diphenylphyraline hydrochloride, Tripelenamine   hydrochloride,   Chlorcyclizine   hydrochloride,   Meclizine hydrochloride, Buclizine hydrochloride, Chlorpheniramine maleate, Triprolidine hydrochloride*,   Phenidamine   tartarate,   Promethazine   hydrochloride*, Trimeprazine  tartrate,  Cyproheptadine  hydrochloride,  Azatidine  maleate, Astemizole, Loratadine, Cetirizine, Levocetrazine Cromolyn sodium</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 11pt;padding-left: 33pt;text-indent: 0pt;text-align: justify;">H<span class="s1">2</span>-antagonists: <span class="p">Cimetidine*, Famotidine, Ranitidin.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 9pt;padding-left: 33pt;text-indent: 0pt;text-align: justify;">Gastric Proton pump inhibitors: <span class="p">Omeprazole, Lansoprazole, Rabeprazole, Pantoprazole</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 33pt;text-indent: 0pt;text-align: justify;">Anti-neoplastic agents:</h2><h2 style="padding-top: 5pt;padding-left: 33pt;text-indent: 0pt;text-align: justify;">Alkylating  agents:  <span class="p">Meclorethamine*,  Cyclophosphamide,  Melphalan,</span></h2><p style="padding-top: 3pt;padding-left: 33pt;text-indent: 0pt;text-align: justify;">Chlorambucil, Busulfan, Thiotepa</p><h2 style="padding-top: 5pt;padding-left: 33pt;text-indent: 0pt;text-align: justify;">Antimetabolites:  <span class="p">Mercaptopurine*,  Thioguanine,  Fluorouracil,  Floxuridine, Cytarabine, Methotrexate*, Azathioprine</span></h2><h2 style="padding-top: 6pt;padding-left: 33pt;text-indent: 0pt;line-height: 143%;text-align: justify;">Antibiotics: <span class="p">Dactinomycin, Daunorubicin, Doxorubicin, Bleomycin </span>Plant products: <span class="p">Etoposide, Vinblastin sulphate, Vincristin sulphate </span>Miscellaneous: <span class="p">Cisplatin, Mitotane.</span></h2><h2 style="padding-top: 7pt;padding-left: 21pt;text-indent: 0pt;text-align: left;">UNIT – II                               10 Hours</h2><h2 style="padding-top: 11pt;padding-left: 33pt;text-indent: 0pt;text-align: left;">Anti-anginal<span class="p">:</span></h2><h2 style="padding-top: 8pt;padding-left: 33pt;text-indent: 0pt;text-align: left;">Vasodilators: <span class="p">Amyl nitrite, Nitroglycerin*, Pentaerythritol tetranitrate, Isosorbide dinitrite*, Dipyridamole.</span></h2><h2 style="padding-top: 7pt;padding-left: 33pt;text-indent: 0pt;text-align: left;">Calcium  channel  blockers:  <span class="p">Verapamil,  Bepridil  hydrochloride,  Diltiazem hydrochloride, Nifedipine, Amlodipine, Felodipine, Nicardipine, Nimodipine.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 33pt;text-indent: 0pt;text-align: left;">Diuretics:</h2><p style="padding-top: 7pt;padding-left: 33pt;text-indent: 0pt;text-align: left;">Carbonic   anhydrase   inhibitors:   Acetazolamide*,   Methazolamide, Dichlorphenamide.</p><p style="padding-top: 6pt;padding-left: 33pt;text-indent: 0pt;text-align: left;">Thiazides:   Chlorthiazide*,   Hydrochlorothiazide,   Hydroflumethiazide, Cyclothiazide,</p><p style="padding-top: 6pt;padding-left: 33pt;text-indent: 0pt;line-height: 150%;text-align: left;">Loop diuretics: Furosemide*, Bumetanide, Ethacrynic acid. Potassium sparing Diuretics: Spironolactone, Triamterene, Amiloride. Osmotic Diuretics: Mannitol</p><h2 style="padding-top: 5pt;padding-left: 33pt;text-indent: 0pt;text-align: justify;">Anti-hypertensive Agents<span class="p">: Timolol, Captopril, Lisinopril, Enalapril, Benazepril hydrochloride, Quinapril hydrochloride, Methyldopate hydrochloride,* Clonidine hydrochloride,  Guanethidine  monosulphate,  Guanabenz  acetate,  Sodium nitroprusside, Diazoxide, Minoxidil, Reserpine, Hydralazine hydrochloride.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 21pt;text-indent: 0pt;text-align: left;">UNIT- III                                    10 Hours</h2><h2 style="padding-top: 11pt;padding-left: 38pt;text-indent: 0pt;text-align: justify;">Anti-arrhythmic  Drugs<span class="p">:  Quinidine  sulphate,  Procainamide  hydrochloride, Disopyramide  phosphate*,  Phenytoin  sodium,  Lidocaine  hydrochloride, Tocainide hydrochloride, Mexiletine hydrochloride, Lorcainide hydrochloride, Amiodarone, Sotalol.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 38pt;text-indent: 0pt;text-align: left;">Anti-hyperlipidemic  agents<span class="p">:  Clofibrate,  Lovastatin,  Cholesteramine  and Cholestipol</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 38pt;text-indent: 0pt;text-align: left;">Coagulant  &amp;  Anticoagulants<span class="p">:  Menadione,  Acetomenadione,  Warfarin*, Anisindione, clopidogrel</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 38pt;text-indent: 0pt;line-height: 124%;text-align: left;">Drugs used in Congestive Heart Failure: <span class="p">Digoxin, Digitoxin, Nesiritide, Bosentan, Tezosentan.</span></h2><h2 style="padding-top: 3pt;padding-left: 21pt;text-indent: 0pt;text-align: left;">UNIT- IV                                    08 Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 33pt;text-indent: 0pt;text-align: left;">Drugs acting on Endocrine system</h2><p style="padding-top: 5pt;padding-left: 33pt;text-indent: 0pt;text-align: left;">Nomenclature, Stereochemistry and metabolism of steroids</p><h2 style="padding-top: 6pt;padding-left: 33pt;text-indent: 0pt;text-align: left;">Sex hormones<span class="p">: Testosterone, Nandralone, Progestrones, Oestriol, Oestradiol, Oestrione, Diethyl stilbestrol.</span></h2><h2 style="padding-left: 33pt;text-indent: 0pt;text-align: left;">Drugs for erectile dysfunction: <span class="p">Sildenafil, Tadalafil.</span></h2><h2 style="padding-left: 33pt;text-indent: 0pt;text-align: left;">Oral contraceptives: <span class="p">Mifepristone, Norgestril, Levonorgestrol</span></h2><h2 style="padding-left: 33pt;text-indent: 0pt;text-align: left;">Corticosteroids:  <span class="p">Cortisone,  Hydrocortisone,  Prednisolone,  Betamethasone, Dexamethasone</span></h2><h2 style="padding-left: 33pt;text-indent: 0pt;text-align: left;">Thyroid and antithyroid drugs<span class="p">: L-Thyroxine, L-Thyronine, Propylthiouracil, Methimazole.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 21pt;text-indent: 0pt;text-align: left;">UNIT – V                                    07 Hours</h2><h2 style="padding-top: 8pt;padding-left: 38pt;text-indent: 0pt;text-align: left;">Antidiabetic agents:</h2><p style="padding-top: 6pt;padding-left: 38pt;text-indent: 0pt;text-align: left;">Insulin and its preparations</p><p style="padding-top: 7pt;padding-left: 38pt;text-indent: 0pt;line-height: 150%;text-align: left;">Sulfonyl ureas: Tolbutamide*, Chlorpropamide, Glipizide, Glimepiride. Biguanides: Metformin.</p><p style="padding-left: 38pt;text-indent: 0pt;line-height: 150%;text-align: left;">Thiazolidinediones: Pioglitazone, Rosiglitazone. Meglitinides: Repaglinide, Nateglinide.</p><p style="padding-left: 38pt;text-indent: 0pt;text-align: left;">Glucosidase inhibitors: Acrabose, Voglibose.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 38pt;text-indent: 0pt;text-align: left;">Local Anesthetics: <span class="p">SAR of Local anesthetics</span></h2><h2 style="padding-top: 7pt;padding-left: 38pt;text-indent: 0pt;text-align: left;">Benzoic Acid derivatives<span class="p">; Cocaine, Hexylcaine, Meprylcaine, Cyclomethycaine, Piperocaine.</span></h2><h2 style="padding-top: 6pt;padding-left: 38pt;text-indent: 0pt;text-align: left;">Amino Benzoic acid derivatives<span class="p">: Benzocaine*, Butamben, Procaine*, Butacaine, Propoxycaine, Tetracaine, Benoxinate.</span></h2><h2 style="padding-top: 6pt;padding-left: 38pt;text-indent: 0pt;text-align: left;">Lidocaine/Anilide derivatives<span class="p">: Lignocaine, Mepivacaine, Prilocaine, Etidocaine.</span></h2><h2 style="padding-top: 6pt;padding-left: 38pt;text-indent: 0pt;text-align: left;">Miscellaneous<span class="p">: Phenacaine, Diperodon, Dibucaine.*</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Recommended Books (Latest Editions)</h2><ol id="l2"><li data-list-text="1."><p style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Wilson and Giswold’s Organic medicinal and Pharmaceutical Chemistry.</p></li><li data-list-text="2."><p style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Foye’s Principles of Medicinal Chemistry.</p></li><li data-list-text="3."><p style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Burger’s Medicinal Chemistry, Vol I to IV.</p></li><li data-list-text="4."><p style="padding-left: 34pt;text-indent: -12pt;text-align: left;">Introduction to principles of drug design- Smith and Williams.</p></li><li data-list-text="5."><p style="padding-left: 33pt;text-indent: -11pt;text-align: left;">Remington’s Pharmaceutical Sciences.</p></li><li data-list-text="6."><p style="padding-left: 33pt;text-indent: -11pt;text-align: left;">Martindale’s extra pharmacopoeia.</p></li><li data-list-text="7."><p style="padding-left: 33pt;text-indent: -11pt;text-align: left;">Organic Chemistry by I.L. Finar, Vol. II.</p></li><li data-list-text="8."><p style="padding-top: 2pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">The Organic Chemistry of Drug Synthesis by Lednicer, Vol. 1to 5.</p></li><li data-list-text="9."><p style="padding-left: 34pt;text-indent: -12pt;text-align: left;">Indian Pharmacopoeia.</p></li><li data-list-text="10."><p style="padding-left: 39pt;text-indent: -17pt;text-align: left;">Tex​t book of practical organic chemistry- A.I.Vogel.</p><h2 style="padding-top: 3pt;padding-left: 106pt;text-indent: 0pt;text-align: left;">PY 502. Industrial PharmacyI (Theory)</h2><h2 style="padding-top: 6pt;padding-left: 407pt;text-indent: 0pt;text-align: left;">45 Hours</h2><h2 style="padding-top: 4pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Scope<span class="p">: Course enables the student to understand and appreciate the influence of pharmaceutical additives and various pharmaceutical dosage forms on the performance of the drug product.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 10pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Objectives: <span class="p">Upon completion of the course the student shall be able to</span></h2><ol id="l3"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -18pt;text-align: left;">Kn​ow the various pharmaceutical dosage forms and their manufacturing techniques.</p></li><li data-list-text="2."><p style="padding-top: 6pt;padding-left: 57pt;text-indent: -17pt;text-align: left;">Kn​ow various considerations in development of pharmaceutical dosage forms</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -18pt;text-align: left;">Fo​rmulate solid, liquid and semisolid dosage forms and evaluate them for their quality</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 22pt;text-indent: 0pt;text-align: center;">Course content:</h2><h2 style="padding-top: 6pt;padding-left: 381pt;text-indent: 0pt;text-align: center;">3 hours/ week</h2><h2 style="padding-top: 5pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-I                                     07 Hours</h2><h2 style="padding-top: 5pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Preformulation Studies: <span class="p">Introduction to preformulation, goals and objectives, study of physicochemical characteristics of drug substances.</span></h2><ol id="l4"><li data-list-text="a."><p class="s2" style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Physical properties: <span class="p">Physical form (crystal &amp; amorphous), particle size, shape, flow properties, solubility profile (pKa, pH, partition coefficient), polymorphism</span></p></li><li data-list-text="b."><p class="s2" style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;line-height: 143%;text-align: left;">Chemical Properties: <span class="p">Hydrolysis, oxidation, reduction, racemisation, polymerization BCS classification of drugs &amp; its significant</span></p></li></ol><p style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Application of preformulation considerations in the development of solid, liquid oral and parenteral dosage forms and its impact on stability of dosage forms.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 11pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-II                                     10 Hours</h2><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Tablets:</h2><ol id="l5"><li data-list-text="a."><p style="padding-top: 5pt;padding-left: 50pt;text-indent: -28pt;text-align: justify;">	Introduction, ideal characteristics of tablets, classification of tablets. Excipients, Formulation of tablets, granulation methods, compression and processing problems. Equipments and tablet tooling.</p></li><li data-list-text="b."><p style="padding-top: 6pt;padding-left: 50pt;text-indent: -28pt;text-align: justify;">Tablet coating: Types of coating, coating materials, formulation of coating composition, methods of coating, equipment employed and defects in coating.</p></li><li data-list-text="c."><p style="padding-top: 6pt;padding-left: 50pt;text-indent: -28pt;text-align: justify;">Quality control tests: In process and finished product tests</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 10pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Liquid orals: <span class="p">Formulation and manufacturing consideration of syrups and elixirs suspensions and  emulsions;  Filling  and  packaging;  evaluation  of  liquid  orals official in pharmacopoeia</span></h2><h2 style="padding-top: 3pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-III                                       08 Hours</h2><h2 style="padding-top: 5pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Capsules:</h2><ol id="l6"><li data-list-text="a."><p style="padding-top: 5pt;padding-left: 43pt;text-indent: -14pt;text-align: justify;">	<i><b>Hard gelatin capsules: </b></i>Introduction, Production of hard gelatin capsule shells. size of capsules, Filling, finishing and special techniques of formulation of hard gelatin capsules, manufacturing defects. In process and final product quality control tests for capsules.</p></li><li data-list-text="b."><p class="s2" style="padding-top: 6pt;padding-left: 43pt;text-indent: -14pt;text-align: justify;">Soft  gelatin  capsules:  <span class="p">Nature  of  shell  and  capsule  content,  size  of capsules,importance of base adsorption and minim/gram factors, production, in process and final product quality control tests. Packing, storage and stability testing of soft gelatin capsules and their applications.</span></p></li></ol></li></ol><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Pellets: <span class="p">Introduction, formulation requirements, pelletization process, equipments for manufacture of pellets</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 11pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-IV                                    10 Hours</h2><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Parenteral Products:</h2><ol id="l7"><li data-list-text="a."><p style="padding-top: 5pt;padding-left: 36pt;text-indent: -14pt;text-align: left;">Definition, types, advantages and limitations. Preformulation factors and essential requirements, vehicles, additives, importance of isotonicity</p></li><li data-list-text="b."><p style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Production procedure, production facilities and controls, aseptic processing</p></li><li data-list-text="c."><p style="padding-top: 5pt;padding-left: 36pt;text-indent: -14pt;text-align: left;">Formulation of injections, sterile powders, large volume parenterals and lyophilized products.</p></li><li data-list-text="d."><p style="padding-top: 6pt;padding-left: 36pt;text-indent: -14pt;text-align: left;">Containers and closures selection, filling and sealing of ampoules, vials and infusion fluids. Quality control tests of parenteral products.</p><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Ophthalmic Preparations: <span class="p">Introduction, formulation considerations; formulation of eye drops, eye ointments and eye lotions; methods of preparation; labeling, containers; evaluation of ophthalmic preparations</span></h2><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-V                                     10 Hours</h2><h2 style="padding-top: 5pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Cosmetics: <span class="p">Formulation and preparation of the following cosmetic preparations: lipsticks, shampoos, cold cream and vanishing cream, tooth pastes, hair dyes and sunscreens.</span></h2><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Pharmaceutical Aerosols: <span class="p">Definition, propellants, containers, valves, types of aerosol systems; formulation and manufacture of aerosols; Evaluation of aerosols; Quality control and stability studies.</span></h2><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Packaging Materials Science: <span class="p">Materials used for packaging of pharmaceutical products, factors influencing choice of containers, legal and official requirements for containers, stability aspects of packaging materials, quality control tests.</span></h2><h2 style="padding-top: 3pt;padding-left: 120pt;text-indent: 0pt;text-align: left;">Industrial Pharmacy I (Practical)</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l8"><li data-list-text="1."><p style="padding-top: 10pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Preformulation studies on paracetamol/asparin/or any other drug</p></li><li data-list-text="2."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Preparation and evaluation of Paracetamol tablets</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Preparation and evaluation of Aspirin tablets</p></li><li data-list-text="4."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Coating of tablets- film coating of tables/granules</p></li><li data-list-text="5."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Preparation and evaluation of Tetracycline capsules</p></li><li data-list-text="6."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Preparation of Calcium Gluconate injection</p></li><li data-list-text="7."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Preparation of Ascorbic Acid injection</p></li><li data-list-text="8."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Qulaity control test of (as per IP) marketed tablets and capsules</p></li><li data-list-text="9."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Preparation of Eye drops/ and Eye ointments</p></li><li data-list-text="10."><p style="padding-top: 5pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Preparation of Creams (cold / vanishing cream)</p></li><li data-list-text="11."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -21pt;text-align: left;">Evaluation of Glass containers (as per IP)</p></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 8pt;padding-left: 14pt;text-indent: 0pt;text-align: left;">4 Hours/week</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Recommended Books: (Latest Editions)</h2><ol id="l9"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 44pt;text-indent: -22pt;text-align: left;">Ph​armaceutical dosage forms - Tablets, volume 1 -3 by H.A. Liberman, Leon Lachman &amp;J.B.Schwartz</p></li><li data-list-text="2."><p style="padding-top: 6pt;padding-left: 44pt;text-indent: -22pt;text-align: left;">Ph​armaceutical dosage form - Parenteral medication vol- 1&amp;2 by Liberman &amp; Lachman</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Ph​armaceutical dosage form disperse system VOL-1 by Liberman &amp; Lachman</p></li><li data-list-text="4."><p style="padding-top: 6pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Mo​dern Pharmaceutics by Gilbert S. Banker &amp; C.T. Rhodes, 3rd Edition</p></li><li data-list-text="5."><p style="padding-top: 6pt;padding-left: 44pt;text-indent: -22pt;text-align: left;">Re​mington: The Science and Practice of Pharmacy, 20th edition Pharmaceutical Science (RPS)</p></li><li data-list-text="6."><p style="padding-top: 6pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Th​eory and Practice of Industrial Pharmacy by Liberman &amp; Lachman</p></li><li data-list-text="7."><p style="padding-top: 6pt;padding-left: 44pt;text-indent: -22pt;text-align: left;">Ph​armaceutics- The science of dosage form design by M.E.Aulton, Churchill livingstone, Latest edition</p></li><li data-list-text="8."><p style="padding-top: 6pt;padding-left: 44pt;text-indent: -22pt;text-align: left;">In​troduction to Pharmaceutical Dosage Forms by H. C.Ansel, Lea &amp;Febiger, Philadelphia, 5<span class="s3">th</span>edition, 2005</p></li><li data-list-text="9."><p style="padding-top: 5pt;padding-left: 44pt;text-indent: -22pt;text-align: left;">Dr​ug stability - Principles and practice by Cartensen &amp; C.J. Rhodes, 3rd Edition, Marcel Dekker Series, Vol 107.</p><h2 style="padding-top: 3pt;padding-left: 15pt;text-indent: 0pt;text-align: center;">PY 503. PHARMACOLOGY-II (Theory)</h2><h2 style="text-indent: 0pt;text-align: right;">45 Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Scope: <span class="p">This subject is intended to impart the fundamental knowledge on various aspects (classification, mechanism of action, therapeutic effects, clinical uses, side effects and contraindications) of drugs acting on different systems of body and in addition,emphasis on the basic concepts of bioassay.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Objectives: <span class="p">Upon completion of this course the student should be able to</span></h2><ol id="l10"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -18pt;text-align: left;">Un​derstand the mechanism of drug action and its relevance in the treatment of different diseases</p></li><li data-list-text="2."><p style="padding-left: 58pt;text-indent: -18pt;text-align: left;">De​monstrate isolation of different organs/tissues from the laboratory animals by simulated experiments</p></li><li data-list-text="3."><p style="padding-left: 58pt;text-indent: -17pt;text-align: left;">De​monstrate the various receptor actions using isolated tissue preparation</p></li><li data-list-text="4."><p style="padding-left: 57pt;text-indent: -17pt;text-align: left;">Ap​preciate correlation of pharmacology with related medical sciences</p></li></ol></li></ol></li></ol></li></ol><h2 style="padding-top: 6pt;padding-left: 195pt;text-indent: 0pt;text-align: left;">Course Content:</h2><h2 style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-I                                     10hours</h2><ol id="l11"><li data-list-text="1."><h2 style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Pharmacology of drugs acting on cardio vascular system</h2><ol id="l12"><li data-list-text="a."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Introduction to hemodynamic and electrophysiology of heart.</p></li><li data-list-text="b."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Drugs used in congestive heart failure</p></li><li data-list-text="c."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Anti-hypertensive drugs.</p></li><li data-list-text="d."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Anti-anginal drugs.</p></li><li data-list-text="e."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Anti-arrhythmic drugs.</p></li><li data-list-text="f."><p style="padding-left: 67pt;text-indent: -9pt;line-height: 14pt;text-align: left;">Anti-hyperlipidemic drugs.</p></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-II                                     10hours</h2><ol id="l13"><li data-list-text="1."><h2 style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Pharmacology of drugs acting on cardio vascular system</h2><ol id="l14"><li data-list-text="a."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Drug used in the therapy of shock.</p></li><li data-list-text="b."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Hematinics, coagulants and anticoagulants.</p></li><li data-list-text="c."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Fibrinolytics and anti-platelet drugs</p></li><li data-list-text="d."><p style="padding-left: 69pt;text-indent: -11pt;text-align: left;">Plasma volume expanders</p></li></ol></li><li data-list-text="2."><h2 style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Pharmacology of drugs acting on urinary system</h2><ol id="l15"><li data-list-text="a."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Diuretics</p></li><li data-list-text="b."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Anti-diuretics.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-III                                    10hours</h2></li></ol></li><li data-list-text="3."><h2 style="padding-left: 36pt;text-indent: -14pt;line-height: 14pt;text-align: left;">Autocoids and related drugs</h2><ol id="l16"><li data-list-text="a."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Introduction to autacoids and classification</p></li><li data-list-text="b."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Histamine, 5-HT and their antagonists.</p></li><li data-list-text="c."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Prostaglandins, Thromboxanes and Leukotrienes.</p></li><li data-list-text="d."><p style="padding-left: 69pt;text-indent: -11pt;text-align: left;">Angiotensin, Bradykinin and Substance P.</p></li><li data-list-text="e."><p style="padding-left: 69pt;text-indent: -11pt;text-align: left;">Non-steroidal anti-inflammatory agents</p></li><li data-list-text="f."><p style="padding-left: 67pt;text-indent: -9pt;text-align: left;">Anti-gout drugs</p></li><li data-list-text="g."><p style="padding-left: 69pt;text-indent: -11pt;text-align: left;">Antirheumatic drugs</p></li></ol></li></ol><h2 style="padding-top: 3pt;padding-left: 22pt;text-indent: 0pt;line-height: 14pt;text-align: left;">UNIT-IV                                    08hours</h2><ol id="l17"><li data-list-text="5."><h2 style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Pharmacology of drugs acting on endocrine system</h2><ol id="l18"><li data-list-text="a."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Basic concepts in endocrine pharmacology.</p></li><li data-list-text="b."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Anterior Pituitary hormones- analogues and their inhibitors.</p></li><li data-list-text="c."><p style="padding-left: 68pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Thyroid hormones- analogues and their inhibitors.</p></li><li data-list-text="d."><p style="padding-left: 71pt;text-indent: -14pt;text-align: left;">Hormones regulating plasma calcium level- Parathormone, Calcitonin and Vitamin-D.</p></li></ol></li></ol><p style="padding-left: 58pt;text-indent: 0pt;text-align: left;">d. Insulin, Oral Hypoglycemic agents and glucagon.</p><p style="padding-left: 58pt;text-indent: 0pt;text-align: left;">e. ACTH and corticosteroids.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-V                                     07hours</h2><ol id="l19"><li data-list-text="5."><h2 style="padding-left: 33pt;text-indent: -11pt;text-align: left;">Pharmacology of drugs acting on endocrine system</h2><ol id="l20"><li data-list-text="a."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Androgens and Anabolic steroids.</p></li><li data-list-text="b."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Estrogens, progesterone and oral contraceptives.</p></li><li data-list-text="c."><p style="padding-left: 69pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Drugs acting on the uterus.</p></li></ol></li><li data-list-text="6."><h2 style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Bioassay</h2><ol id="l21"><li data-list-text="a."><p style="padding-left: 33pt;text-indent: -11pt;line-height: 14pt;text-align: left;">Principles and applications of bioassay.</p></li><li data-list-text="b."><p style="padding-left: 30pt;text-indent: -8pt;line-height: 14pt;text-align: left;">Types of bioassay</p></li><li data-list-text="c."><p style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Bioassay of insulin, oxytocin, vasopressin, ACTH,d-tubocurarine,digitalis, histamine and 5-HT</p><h2 style="padding-top: 3pt;padding-left: 123pt;text-indent: 0pt;text-align: left;">PHARMACOLOGY-II (Practical)</h2><h2 style="text-indent: 0pt;text-align: right;">4Hrs/Week</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l22"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 51pt;text-indent: -14pt;text-align: left;">Introduction to <i>in-vitro </i>pharmacology and physiological salt solutions.</p></li><li data-list-text="2."><p style="padding-left: 50pt;text-indent: -14pt;line-height: 14pt;text-align: left;">Effect of drugs on isolated frog heart.</p></li><li data-list-text="3."><p style="padding-left: 50pt;text-indent: -14pt;line-height: 14pt;text-align: left;">Effect of drugs on blood pressure and heart rate of dog.</p></li><li data-list-text="4."><p style="padding-left: 50pt;text-indent: -14pt;text-align: left;">Study of diuretic activity of drugs using rats/mice.</p></li><li data-list-text="5."><p style="padding-left: 50pt;text-indent: -14pt;text-align: left;">DRC of acetylcholine using frog rectus abdominis muscle.</p></li><li data-list-text="6."><p style="padding-left: 50pt;text-indent: -14pt;text-align: left;">Effect of physostigmine and atropine on DRC of acetylcholine using frog rectus abdominis muscle and rat ileum respectively.</p></li><li data-list-text="7."><p style="padding-left: 50pt;text-indent: -14pt;line-height: 14pt;text-align: left;">Bioassay of histamine using guinea pig ileum by matching method.</p></li><li data-list-text="8."><p style="padding-left: 50pt;text-indent: -14pt;line-height: 14pt;text-align: left;">Bioassay of oxytocin using rat uterine horn by interpolation method.</p></li><li data-list-text="9."><p style="padding-left: 50pt;text-indent: -14pt;line-height: 14pt;text-align: left;">Bioassay of serotonin using rat fundus strip by three point bioassay.</p></li><li data-list-text="10."><p style="padding-left: 57pt;text-indent: -21pt;text-align: left;">Bioassay of acetylcholine using rat ileum/colon by four point bioassay.</p></li><li data-list-text="11."><p style="padding-left: 50pt;text-indent: -14pt;text-align: left;">Determination of PA<span class="s5">2</span> value of prazosin using rat anococcygeus muscle (by Schilds plot method).</p></li><li data-list-text="12."><p style="padding-left: 57pt;text-indent: -21pt;line-height: 14pt;text-align: left;">Determination of PD<span class="s5">2</span> value using guinea pig ileum.</p></li><li data-list-text="13."><p style="padding-left: 57pt;text-indent: -21pt;line-height: 14pt;text-align: left;">Effect of spasmogens and spasmolytics using rabbit jejunum.</p></li><li data-list-text="14."><p style="padding-left: 50pt;text-indent: -14pt;text-align: left;">Anti-inflammatory activity of drugs using carrageenan induced paw-edema model.</p></li><li data-list-text="15."><p style="padding-left: 57pt;text-indent: -21pt;text-align: left;">Analgesic activity of drug using central and peripheral methods</p></li></ol></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s4" style="padding-top: 10pt;padding-left: 53pt;text-indent: -31pt;text-align: left;">Note: All laboratory techniques and animal experiments are demonstrated by simulated experiments by softwares and videos</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 11pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest Editions)</h2><ol id="l23"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 40pt;text-indent: -18pt;text-align: left;">Rang H. P., Dale M. M., Ritter J. M., Flower R. J., Rang and Dale’s Pharmacology, Churchil Livingstone Elsevier</p></li><li data-list-text="2."><p style="padding-left: 40pt;text-indent: -18pt;text-align: left;">Katzung B. G., Masters S. B., Trevor A. J., Basic and clinical pharmacology, Tata Mc Graw-Hill.</p></li><li data-list-text="3."><p style="padding-left: 39pt;text-indent: -17pt;text-align: left;">Goodman and Gilman’s, The Pharmacological Basis of Therapeutics</p></li><li data-list-text="4."><p style="padding-left: 40pt;text-indent: -18pt;text-align: left;">Marry Anne K. K., Lloyd Yee Y., Brian K. A., Robbin L.C., Joseph G. B., Wayne A. K., Bradley R.W., Applied Therapeutics, The Clinical use of Drugs, The Point Lippincott Williams &amp; Wilkins.</p></li><li data-list-text="5."><p style="padding-left: 40pt;text-indent: -18pt;text-align: left;">Mycek M.J, Gelnet S.B and Perper M.M. Lippincott’s Illustrated Reviews- Pharmacology.</p></li><li data-list-text="6."><p style="padding-left: 40pt;text-indent: -18pt;text-align: left;">K.D.Tripathi. Essentials of Medical Pharmacology, , JAYPEE Brothers Medical Publishers (P) Ltd, New Delhi.</p></li><li data-list-text="7."><p style="padding-left: 39pt;text-indent: -17pt;text-align: left;">Sharma H. L., Sharma K. K., Principles of Pharmacology, Paras medical publisher</p></li><li data-list-text="8."><p style="padding-left: 39pt;text-indent: -17pt;text-align: left;">Modern Pharmacology with clinical Applications, by Charles R.Craig&amp; Robert.</p></li><li data-list-text="9."><p style="padding-left: 40pt;text-indent: -18pt;text-align: left;">Ghosh MN. Fundamentals of Experimental Pharmacology. Hilton &amp; Company, Kolkata.</p></li><li data-list-text="10."><p style="padding-left: 39pt;text-indent: -17pt;text-align: left;">Kulkarni SK. Handbook of experimental pharmacology. Vallabh Prakashan.</p><h3 style="padding-top: 3pt;padding-left: 16pt;text-indent: 0pt;line-height: 13pt;text-align: center;">PY 504. PHARMACOGNOSY AND PHYTOCHEMISTRY II (Theory)</h3><h3 style="padding-left: 22pt;text-indent: 360pt;text-align: left;">45Hours Scope: <span class="s6">The main purpose of subject is to impart the students the knowledge of how the secondary metabolites are produced in the crude drugs, how to isolate and identify and produce them industrially. Also this subject involves the study of producing the plants and phytochemicals through plant tissue culture, drug interactions and basic principles of traditional system of medicine</span></h3><h3 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Objectives: <span class="s6">Upon completion of the course, the student shall be able</span></h3><ol id="l24"><li data-list-text="1."><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">to know the modern extraction techniques, characterization and identification of the herbal drugs and phytoconstituents</p></li><li data-list-text="2."><p class="s6" style="padding-left: 58pt;text-indent: -17pt;text-align: left;">to understand the preparation and development of herbal formulation.</p></li><li data-list-text="3."><p class="s6" style="padding-top: 1pt;padding-left: 57pt;text-indent: -17pt;text-align: left;">to understand the herbal drug interactions</p></li><li data-list-text="4."><p class="s6" style="padding-top: 1pt;padding-left: 57pt;text-indent: -17pt;text-align: left;">to carryout isolation and identification of phytoconstituents</p></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: center;">Course Content:</h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT-I                                       7 Hours</h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Metabolic pathways in higher plants and their determination</h3><ol id="l25"><li data-list-text="a)"><p class="s6" style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Brief study of basic metabolic pathways and formation of different secondary metabolites through these pathways- Shikimic acid pathway, Acetate pathways and Amino acid pathway.</p></li><li data-list-text="b)"><p class="s6" style="padding-left: 34pt;text-indent: -12pt;line-height: 13pt;text-align: left;">Study of utilization of radioactive isotopes in the investigation of Biogenetic studies.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-II                                      14 Hours</h3><p class="s6" style="padding-left: 22pt;text-indent: 0pt;text-align: left;">General introduction, composition, chemistry &amp; chemical classes, biosources, therapeutic uses and commercial applications of following</p><p class="s6" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">secondary metabolites:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Alkaloids: <span class="s6">Vinca, Rauwolfia, Belladonna, Opium,</span></h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Phenylpropanoids and Flavonoids: <span class="s6">Lignans, Tea, Ruta</span></h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Steroids, Cardiac Glycosides &amp; Triterpenoids<span class="s6">: Liquorice, Dioscorea, Digitalis</span></h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Volatile oils<span class="s6">: Mentha, Clove, Cinnamon, Fennel, Coriander,</span></h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Tannins: <span class="s6">Catechu, Pterocarpus</span></h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Resins: <span class="s6">Benzoin, Guggul, Ginger, Asafoetida, Myrrh, Colophony</span></h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Glycosides: <span class="s6">Senna, Aloes, Bitter Almond</span></h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Iridoids, Other terpenoids &amp; Naphthaquinones: <span class="s6">Gentian, Artemisia, taxus, carotenoids</span></h3><h3 style="padding-top: 8pt;padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT-III                                     06 Hours</h3><p class="s6" style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Isolation, Identification and Analysis of Phytoconstituents</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l26"><li data-list-text="a)"><p class="s6" style="padding-left: 57pt;text-indent: -17pt;text-align: left;">Terpenoids: Menthol, Citral, Artemisin</p></li><li data-list-text="b)"><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">Glycosides: Glycyrhetinic acid &amp; Rutin</p></li><li data-list-text="c)"><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Alkaloids: Atropine,Quinine,Reserpine,Caffeine</p></li><li data-list-text="d)"><p class="s6" style="padding-left: 58pt;text-indent: -18pt;line-height: 13pt;text-align: left;">Resins: Podophyllotoxin, Curcumin</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT-IV                                     10 Hours</h3><p class="s6" style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Industrial production, estimation and utilization of the following phytoconstituents: Forskolin, Sennoside, Artemisinin, Diosgenin, Digoxin, Atropine, Podophyllotoxin, Caffeine, Taxol, Vincristine and Vinblastine</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT V                                     8 Hours</h3><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Basics of Phytochemistry</h3><p class="s6" style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Modern methods of extraction, application of latest techniques like Spectroscopy, chromatography and electrophoresis in the isolation, purification and identification of crude drugs.</p><h3 style="padding-top: 3pt;padding-left: 52pt;text-indent: 0pt;line-height: 13pt;text-align: left;">PHARMACOGNOSY AND PHYTOCHEMISTRY II (Practical)</h3><h3 style="text-indent: 0pt;line-height: 13pt;text-align: right;">4 Hours/Week</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l27"><li data-list-text="1."><p class="s6" style="padding-top: 4pt;padding-left: 58pt;text-indent: -18pt;text-align: left;">Morphology, histology and powder characteristics &amp; extraction &amp; detection of: Cinchona, Cinnamon, Senna, Clove, Ephedra, Fennel and Coriander</p></li><li data-list-text="2."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Exercise involving isolation &amp; detection of active principles</p><ol id="l28"><li data-list-text="a."><p class="s6" style="padding-left: 75pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Caffeine - from tea dust.</p></li><li data-list-text="b."><p class="s6" style="padding-left: 75pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Diosgenin from Dioscorea</p></li><li data-list-text="c."><p class="s6" style="padding-left: 75pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Atropine from Belladonna</p></li><li data-list-text="d."><p class="s6" style="padding-left: 75pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Sennosides from Senna</p></li></ol></li><li data-list-text="3."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Separation of sugars by Paper chromatography</p></li><li data-list-text="4."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">TLC of herbal extract</p></li><li data-list-text="5."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Distillation of volatile oils and detection of phytoconstitutents by TLC</p></li><li data-list-text="6."><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">Analysis of crude drugs by chemical tests: <b>(</b>i) Asafoetida (ii) Benzoin (iii) Colophony (iv) Aloes (v) Myrrh</p></li></ol></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 22pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Recommended Books: (Latest Editions)</h3><ol id="l29"><li data-list-text="1."><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">	W.C.Evans, Trease and Evans Pharmacognosy, 16<span class="s7">th </span>edition, W.B. Sounders &amp; Co., London, 2009.</p></li><li data-list-text="2."><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">Mohammad Ali. Pharmacognosy and Phytochemistry, CBS Publishers &amp; Distribution, New Delhi.</p></li><li data-list-text="3."><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">Text book of Pharmacognosy by C.K. Kokate, Purohit, Gokhlae (2007), 37<span class="s7">th </span>Edition, Nirali Prakashan, New Delhi.</p></li><li data-list-text="4."><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">Herbal drug industry by R.D. Choudhary (1996), I<span class="s7">st </span>Edn, Eastern Publisher, New Delhi.</p></li><li data-list-text="5."><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">Essentials of Pharmacognosy, Dr.SH.Ansari, IInd edition, Birla publications, New Delhi, 2007</p></li><li data-list-text="6."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Herbal Cosmetics by H.Pande, Asia Pacific Business press, Inc, New Delhi.</p></li><li data-list-text="7."><p class="s6" style="padding-left: 58pt;text-indent: -18pt;text-align: left;">A.N. Kalia, Textbook of Industrial Pharmacognosy, CBS Publishers, New Delhi, 2005.</p></li><li data-list-text="8."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">R Endress, Plant cell Biotechnology, Springer-Verlag, Berlin, 1994.</p></li><li data-list-text="9."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Pharmacognosy &amp; Pharmacobiotechnology. James Bobbers, Marilyn KS, VE Tylor.</p></li><li data-list-text="10."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">The formulation and preparation of cosmetic, fragrances and flavours.</p></li><li data-list-text="11."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Remington’s Pharmaceutical sciences.</p></li><li data-list-text="12."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Text Book of Biotechnology by Vyas and Dixit.</p></li><li data-list-text="13."><p class="s6" style="padding-left: 57pt;text-indent: -17pt;text-align: left;">Text Book of Biotechnology by R.C. Dubey.</p></li></ol><h2 style="padding-top: 3pt;padding-left: 76pt;text-indent: 0pt;text-align: left;">PY 505. PHARMACEUTICAL JURISPRUDENCE (Theory)</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Scope: <span class="p">This course is designed to impart basic knowledge on important legislations related to the profession of pharmacy in India.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 16pt;text-indent: 0pt;text-align: left;">45 Hours</h2><h2 style="padding-top: 5pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Objectives<span class="p">: Upon completion of the course, the student shall be able to understand:</span></h2><ol id="l30"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 58pt;text-indent: -18pt;text-align: left;">The Pharmaceutical legislations and their implications in the development and marketing of pharmaceuticals.</p></li><li data-list-text="2."><p style="padding-left: 57pt;text-indent: -17pt;text-align: left;">Various Indian pharmaceutical Acts and Laws</p></li><li data-list-text="3."><p style="padding-left: 58pt;text-indent: -18pt;text-align: left;">The regulatory authorities and agencies governing the manufacture and sale of pharmaceuticals</p></li><li data-list-text="4."><p style="padding-left: 57pt;text-indent: -17pt;text-align: left;">The code of ethics during the pharmaceutical practice</p></li></ol><h2 style="padding-top: 6pt;padding-left: 195pt;text-indent: 0pt;text-align: left;">Course Content:</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-I                                        10 Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Drugs and Cosmetics Act, 1940 and its rules 1945:</h2><p style="padding-top: 8pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Objectives, Definitions, Legal definitions of schedules to the Act and Rules</p><p style="padding-top: 7pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Import of drugs – Classes of drugs and cosmetics prohibited from import, Import under license or permit. Offences and penalties<b>.</b></p><p style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Manufacture of drugs – Prohibition of manufacture and sale of certain drugs,</p><p style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Conditions for grant of license and conditions of license for manufacture of drugs, Manufacture of drugs for test, examination and analysis, manufacture of new drug, loan license and repacking license.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-II                                       10 Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: justify;">Drugs and Cosmetics Act, 1940 and its rules 1945.</h2><p style="padding-top: 8pt;padding-left: 22pt;text-indent: 0pt;line-height: 150%;text-align: justify;">Detailed study of Schedule G, H, M, N, P,T,U, V, X, Y, Part XII B, Sch F &amp; DMR (OA) Sale of Drugs – Wholesale, Retail sale and Restricted license. Offences and penalties</p><p style="padding-left: 22pt;text-indent: 0pt;text-align: justify;">Labeling &amp; Packing of drugs- General labeling requirements and specimen labels for drugs and cosmetics, List of permitted colors. Offences and penalties.</p><p style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: justify;">Administration of the Act and Rules – Drugs Technical Advisory Board, Central drugs Laboratory, Drugs Consultative Committee, Government drug analysts, Licensing authorities, controlling authorities, Drugs Inspectors</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-III                                       10 Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><ul id="l31"><li data-list-text=""><h2 style="padding-left: 40pt;text-indent: -18pt;line-height: 115%;text-align: justify;">Pharmacy Act –1948<span class="p">: Objectives, Definitions, Pharmacy Council of India; its constitution and functions, Education Regulations, State and Joint state pharmacy councils; constitution and functions, Registration of Pharmacists, Offences and</span></h2><p style="padding-top: 3pt;padding-left: 40pt;text-indent: 0pt;text-align: left;">Penalties</p></li><li data-list-text=""><h2 style="padding-top: 8pt;padding-left: 40pt;text-indent: -18pt;line-height: 113%;text-align: justify;">Medicinal and Toilet Preparation Act –1955<span class="p">: Objectives,  Definitions,  Licensing, Manufacture  In  bond  and  Outside  bond,  Export  of  alcoholic  preparations, Manufacture  of  Ayurvedic,  Homeopathic,  Patent  &amp;  Proprietary  Preparations. Offences and Penalties.</span></h2></li><li data-list-text=""><h2 style="padding-top: 6pt;padding-left: 40pt;text-indent: -18pt;line-height: 113%;text-align: justify;">Narcotic Drugs and Psychotropic substances Act-1985 and Rules<span class="p">: Objectives, Definitions, Authorities and Officers, Constitution and Functions of narcotic &amp; Psychotropic Consultative Committee, National Fund for Controlling the Drug Abuse, Prohibition, Control and Regulation, opium poppy cultivation and production of poppy straw, manufacture, sale and export of opium, Offences and Penalties</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-IV                                       08 Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text=""><h2 style="padding-left: 40pt;text-indent: -18pt;line-height: 112%;text-align: justify;">Study  of  Salient  Features  of  Drugs  and  Magic  Remedies  Act  and  its rules: <span class="p">Objectives, Definitions, Prohibition of certain advertisements, Classes of Exempted advertisements, Offences and Penalties</span></h2></li><li data-list-text=""><h2 style="padding-top: 6pt;padding-left: 40pt;text-indent: -18pt;line-height: 113%;text-align: justify;">Prevention of Cruelty to animals Act-1960: <span class="p">Objectives, Definitions, Institutional Animal Ethics Committee, CPCSEA guidelines for Breeding and Stocking of Animals, Performance of Experiments, Transfer and acquisition of animals for experiment, Records, Power to suspend or revoke registration, Offences and Penalties</span></h2></li><li data-list-text=""><h2 style="padding-top: 6pt;padding-left: 40pt;text-indent: -18pt;line-height: 114%;text-align: left;">National Pharmaceutical Pricing Authority: <span class="p">Drugs Price Control Order (DPCO)- 2013. Objectives, Definitions, Sale prices of bulk drugs, Retail price of formulations, Retail price and ceiling price of scheduled formulations, National List of Essential Medicines (NLEM)</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">UNIT-V                                       07 Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text=""><h2 style="padding-left: 40pt;text-indent: -18pt;line-height: 113%;text-align: justify;">Pharmaceutical Legislations – <span class="p">A brief review, Introduction, Study of drugs enquiry committee, Health survey and  development committee, Hathi committee and Mudaliar committee</span></h2></li><li data-list-text=""><h2 style="padding-top: 6pt;padding-left: 40pt;text-indent: -18pt;line-height: 112%;text-align: justify;">Code of Pharmaceutical ethics <span class="p">D efinition, Pharmacist in relation to his job, trade, medical profession and his profession, Pharmacist’s oath</span></h2></li><li data-list-text=""><h2 style="padding-top: 7pt;padding-left: 39pt;text-indent: -17pt;text-align: justify;">Medical Termination of Pregnancy Act</h2></li><li data-list-text=""><h2 style="padding-top: 8pt;padding-left: 39pt;text-indent: -17pt;text-align: justify;">Right to Information Act</h2></li><li data-list-text=""><h2 style="padding-top: 8pt;padding-left: 39pt;text-indent: -17pt;text-align: left;">Introduction to Intellectual Property Rights (IPR)</h2></li></ul><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Recommended books: (Latest Edition)</h2><ol id="l32"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Forensic Pharmacy by B. Suresh</p></li><li data-list-text="2."><p style="padding-top: 3pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Text book of Forensic Pharmacy by B.M. Mithal</p></li><li data-list-text="3."><p style="padding-top: 5pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Hand book of drug law-by M.L. Mehra</p></li><li data-list-text="4."><p style="padding-top: 6pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">A text book of Forensic Pharmacy by N.K. Jain</p></li><li data-list-text="5."><p style="padding-top: 6pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Drugs and Cosmetics Act/Rules by Govt. of India publications.</p></li><li data-list-text="6."><p style="padding-top: 6pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Medicinal and Toilet preparations act 1955 by Govt. of India publications.</p></li><li data-list-text="7."><p style="padding-top: 6pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Narcotic drugs and psychotropic substances act by Govt. of India publications</p></li><li data-list-text="8."><p style="padding-top: 6pt;padding-left: 33pt;text-indent: -11pt;text-align: left;">Drugs and Magic Remedies act by Govt. of India publication</p></li><li data-list-text="9."><p style="padding-top: 6pt;padding-left: 30pt;text-indent: -8pt;text-align: left;">Bare Acts of the said laws published by Government. Reference books (Theory)</p></li></ol></body></html>
